Biotechnology News This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 27.

Rudimentary Liver Grown in the Lab
From Nature magazine [More]
Source: Scientific American Topic - Stem Cell Research - June 20, 2012 Category: Stem Cells Tags: Health,Biotechnology,More Science,Biotechnology,Biology,Health Source Type: news

Trouble on the horizon for GM crops?
Pests are adapting to genetically modified crops in unexpected ways, including dominant resistance not previously observed in the lab, researchers have discovered. The findings underscore the importance of closely monitoring and countering pest resistance to biotech crops.
Source: ScienceDaily Headlines - June 20, 2012 Category: Science Source Type: news

Trouble on the horizon for genetically modified crops?
Pests are adapting to genetically modified crops in unexpected ways, including dominant resistance not previously observed in the lab, researchers have discovered. The findings underscore the importance of closely monitoring and countering pest resistance to biotech crops.
Source: ScienceDaily Headlines - June 20, 2012 Category: Science Source Type: news

VIDEO: News from BIO
Jeremy Abbate, Director, Global Media Solutions with Scientific American brought together a world-class panel talking about the global community of research and development efforts between the commercial sector, academia and governments. With medicines increasing in costs moving manufacturing tackling government regulations becomes a concern, just as having globally trained scientists work together can help make inroads in biotech. 06/20/2012
Source: Kidney Cancer Association - June 20, 2012 Category: Cancer & Oncology Source Type: news

Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking...
Biotech CEOs and investors to discuss industry issues.(PRWeb June 20, 2012)Read the full story at http://www.prweb.com/releases/BIODebriefReception/06/prweb9621907.htm
Source: PRWeb: Medical Pharmaceuticals - June 20, 2012 Category: Pharmaceuticals Source Type: news

Drug Delivery Technologies Show Promise Of Improving Clinical Outcomes For Patients At Partnership Opportunities In Drug Delivery Conference
In an effort to remove barriers and embrace collaborations to get therapeutics to patients faster, pharmaceutical and biotech companies will listen to more than 25 drug delivery technology presentations, ranging from novel delivery devices to formulation technologies at the 2nd Annual PODD: Partnership Opportunities in Drug Delivery conference, October 1-2, 2012, at the Boston Park Plaza hotel in Boston, MA...
Source: Health News from Medical News Today - June 20, 2012 Category: Consumer Health News Tags: Conferences Source Type: news

Americans and Biotechnology Executives Remain Optimistic About Future of Biotechnology Despite Serious Industry Concerns Over Increased Regulatory Burdens and Weak Economic Conditions
More Than Half of American Biotechnology Firms Say They Have Been Approached to Move Operations and Jobs Overseas BOSTON--(BUSINESS WIRE)--Jun 20, 2012 - The Biotechnology Industry Organization (BIO) today unveiled several new opinion surveys at...
Source: Drugs.com - Pharma News - June 20, 2012 Category: Pharmaceuticals Source Type: news

Six new AIIMS will give fillip to medical research: Ghulam Nabi Azad
Ghulam Nabi Azad today expressed hope that the sector would get a fillip with the coming up of six new AIIMS from next year.
Source: The Economic Times Healthcare and Biotech News - June 20, 2012 Category: Pharmaceuticals Source Type: news

AstraZeneca Completes Acquisition of Ardea Biosciences
SAN DIEGO, CA--(Healthcare Sales & Marketing Network)- AstraZeneca today announced that on Tuesday, June 19, 2012 it completed its acquisition of San Diego, California-based biotechnology company Ardea Biosciences, Inc. The merger was approved by Ardea's s... Biopharmaceuticals, Mergers & AcquisitionsArdea Biosciences, AstraZeneca
Source: HSMN NewsFeed - June 20, 2012 Category: Pharmaceuticals Source Type: news

MichBio: MichBio Leads Effort to Bring Life Science Education, Workforce Training and Entrepreneurship to the National Stage
BOSTON, MA (MARKET WIRE) MichBio, through its MichBio Institute, has joined state bioscience organizations in a nationally coordinated effort to ensure America's leadership in bioscience innovation by delivering industry-led life science education, workforce development and entrepreneurship programs across the country. The MichBio Institute is a member of this newly established group -- the Coalition of State Bioscience Institutes (CSBI). The formation of CSBI was announced at the 2012 BIO International Convention, the industry's global event for biotechnology that is hosted by the Biotechnology Industry
Source: Market Wire - Pharmaceuticals and Biotech - June 20, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news

Indian drug outlook favourable: ICRA & Moody's
According to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of value, globally.
Source: The Economic Times Healthcare and Biotech News - June 20, 2012 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo and Ranbaxy Launch hybrid business in Venezuela
Daiichi Sankyo & Ranbaxy announced that Daiichi Sankyo Venezuela would begin marketing Ranbaxy products in Venezuela as part of hybrid business model.
Source: The Economic Times Healthcare and Biotech News - June 20, 2012 Category: Pharmaceuticals Source Type: news

Sartopore Platinum: Sartorius Introduces A New Generation Of Sterilizing-Grade Filters
SartoriusStedim Biotech (SSB), a leading international pharma and biotech supplier, presents a new generation of sterilizing-grade filters: Sartopore Platinum.
Source: Pharmaceutical Online News - June 20, 2012 Category: Pharmaceuticals Source Type: news

Anatomy Of A Drug Manufacturing Plant (Last In A Three-Part Series Examining The Financial Impact Of New Plant Construction), An Industrial Info News Alert
Reported by Annette Kreuger for Industrial Information Resources Sugar Land, Texas) -- Once construction has wrapped up and the validation process for a new pharmaceutical or biotech (pharma-bio) plant is complete, it is time to begin production.
Source: Pharmaceutical Online News - June 20, 2012 Category: Pharmaceuticals Source Type: news

Outsourcing in Clinical Trials New England-Fourth Annual Clinical Outsourcing Event
One of the most crucial aspects of running a successful clinical trial is finding the right outsourcing partner. Biotech companies rely on CROs and other service providers to complete the operational...
Source: Pharmaceutical Technology - June 19, 2012 Category: Pharmaceuticals Source Type: news

OCT New England-Outsourcing in Clinical Trials Event
Biotech companies rely on CROs and other service providers to take care of the operational aspects of clinical trials and ultimately achieve market approval, so finding a trustworthy and efficient ou...
Source: Drug Development Technology - June 19, 2012 Category: Pharmaceuticals Source Type: news

Biotech M&A: Quietly delivering returns in 2012
Time and again, life sciences VC deals have been outscoring their better-capitalized, super-hyped and oft-praised colleagues who do deals in the tech side of the asset class.
Source: Forbes.com Healthcare News - June 19, 2012 Category: Pharmaceuticals Authors: Bruce Booth Source Type: news

BioFlorida: Jeb’s life-science investment paying off
It wasn't so long ago that the lab rat was supposed to displace Mickey as the state's most important rodent. Turns out Mickey doesn't have anything to worry about. The biotechnology industry and its rats are nowhere close to nudging tourism out of the...
Source: OrlandoSentinel: Medical Research - June 19, 2012 Category: American Health Source Type: news

BIDMC Genomics and Proteomics Center: For Limited Time Introductory 30% Discount on the NEW, Affymetrix GeneChip PrimeView Human Gene Expression Array
BIDMC Genomics and Proteomics Center offers for a Limited Time an Introductory 30% Discount on the NEW, Affymetrix GeneChip PrimeView Human Gene Expression Array. Act now!! Save 30% for this Promotional Discount! Now only $280 per sample (includes array, all reagents and processing costs). Discount expires on June 27, 2012. The GeneChip(r) PrimeView(tm) Human Gene Expression Array provides comprehensive coverage of the human genome in a cartridge array format.Key benefits of the PrimeView(tm) Array:Offers excellent gene expression specificity and reproducibilityProduces reliable results with multiple independent measuremen...
Source: DF/HCC: Latest News - June 19, 2012 Category: Cancer & Oncology Source Type: news

State-subsidized biotech industry beginning to grow, report says
TALLAHASSEE -- The industry group representing Florida's burgeoning biotechnology sector has released a report prepared by the University of Florida that suggests the state's $1.6-billion taxpayer investment in fostering life-science research has...
Source: OrlandoSentinel: Medical Research - June 19, 2012 Category: American Health Source Type: news

Pharmas augment Vitamin D3 capacities to meet demand
Less exposure to sunlight and changing food habits have found to be causing deficiency of Vitamin D3 and active pharmaceutical ingredient-makers see an opportunity in the niche segment.
Source: The Economic Times Healthcare and Biotech News - June 19, 2012 Category: Pharmaceuticals Source Type: news

Fitho Wellness launches tech-based diet planning services
Fitho Wellness Services has launched weight loss diet planning services available as low as Rs 499 per month (approx Rs 16 per day)
Source: The Economic Times Healthcare and Biotech News - June 19, 2012 Category: Pharmaceuticals Source Type: news

BIO 2012, Day 2: Industry Address, New Protests, and E&Y Release Global Biotech Industry Report
Protesters were again outside the BIO 2012 Convention on its second morning. The group was again small but with a very different agenda and much more enthusiastic than the ones yesterday. Rather than promoting an anti-biotech message, they were pushing for fast track release of a new combination cancer drug known as T-DM1, jointly developed by Roche and Immungen. They were upset the FDA refused to accept the companies' application for accelerated approval. For more details, see the story in the Boston Business Journal....Read Full Post
Source: About.com Biotech Biomedical - June 19, 2012 Category: Biotechnology Source Type: news

Trouble on the horizon for GM crops?
(University of Arizona) Pests are adapting to genetically modified crops in unexpected ways, including dominant resistance not previously observed in the lab, researchers have discovered. The findings underscore the importance of closely monitoring and countering pest resistance to biotech crops.
Source: EurekAlert! - Biology - June 19, 2012 Category: Biology Source Type: news

Opening Day of the BIO 2012 Convention in Boston
Today was the first day of the BIO 2012 Convention . As many of you know, the Biotechnology Industry Organization (BIO) is the largest trade association focused on biotechnology. BIO has a membership of about 1,100 companies but the convention attracts about 4 times that with over 15,000 attendees from over 4,000 organizations. A third of these are from outside the US....Read Full Post
Source: About.com Biotech Biomedical - June 18, 2012 Category: Biotechnology Source Type: news

Human Genome Sciences sets acquisition deadline
US biotechnology firm Human Genome Sciences (HGS) has set a deadline of 16 July 2012 for offers to acquire the company, but has failed to tempt GlaxoSmithKline (GSK) into the process.
Source: Pharmaceutical Technology - June 18, 2012 Category: Pharmaceuticals Source Type: news

Sartorius Introduces New Generation of Sterilising-Grade Filters
Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, presents a new generation of sterilising-grade filters, Sartopore® Platinum.
Source: Pharmaceutical Technology - June 18, 2012 Category: Pharmaceuticals Source Type: news

Biotech brings more disappointment than dollar signs
It wasn't so long ago that the lab rat was supposed to displace Mickey as the state's most important rodent. Turns out Mickey doesn't have anything to worry about. The biotechnology industry and its rats are nowhere close to nudging tourism out of the...
Source: OrlandoSentinel: Medical Research - June 18, 2012 Category: American Health Source Type: news

Manchester's MadLab spends time with the FBI
The lively team from the Northern Quarter have just been in California for a conference designed to help the Feds keep up with 'DIY biologists' across the world. Asa Calow was one of themAt MadLab we're used to unusual requests. We run a 3,000 square foot community space for science, technology and art in the centre of Manchester, and as a consequence organise and play host to a wide variety of events - from "hacking" toy robots to play football to making kimchi or dissecting octopuses (and eating them). But back in May we received one of our most unexpected queries yet:I wanted to reach out to everyone to invite you to an...
Source: Guardian Unlimited Science - June 18, 2012 Category: Science Tags: Manchester Metropolitan University Science Biology Technology FBI Lancaster University California University of Manchester University of Salford guardian.co.uk Blogposts UK news Source Type: news

Merck in Potential $300M Research Deal With Ambrx
From Associated Press (June 18, 2012) NEW YORK -- Biotechnology company Ambrx Inc. said Monday that it will receive $15 million and could receive more than $300 million from a new partnership with Merck & Co. to develop drugs using its delivery...
Source: Drugs.com - Pharma News - June 18, 2012 Category: Pharmaceuticals Source Type: news

Fortis seeks shareholders nod for internal restructuring
FHL said it is undertaking an internal restructuring under which some of its hospitals would be divided into two separate verticals.
Source: The Economic Times Healthcare and Biotech News - June 18, 2012 Category: Pharmaceuticals Source Type: news

Drug export up 27% at Rs 60,000 crore in FY 12
India 's exports of drugs, pharmaceutical & fine chemicals grew 27% to Rs 60,000 crore for the year ended March 2012, according to data compiled by Pharmexcil
Source: The Economic Times Healthcare and Biotech News - June 18, 2012 Category: Pharmaceuticals Source Type: news

Bharat Biotech receives $ 4 million award from The Wellcome Trust for Development and Clinical Trials
Vaccine manufacturer Bharat Biotech and The University of Maryland Center for Vaccine Development (CVD) have received $ 4 million from The Wellcome Trust for clinical development
Source: The Economic Times - June 18, 2012 Category: Consumer Health News Source Type: news

India's diabetes drugs market grew 22% at $700 mn
The domestic diabetes drugs market for FY 12 grew 22 per cent at $ 700 million, according to a Credit Suisse report.
Source: The Economic Times Healthcare and Biotech News - June 18, 2012 Category: Pharmaceuticals Source Type: news

HIV Researcher Probes Vulnerabilities in the Virus for Clues to a Vaccine (preview)
The unlikely path that Thumbi Ndung’u followed to become a world-class AIDS researcher began in a rural highland village in Kenya. Ndung’u grew up with five brothers and five sisters in a house with no running water or electricity. He picked coffee beans and milked the family cows when he wasn’t at school. By Kenyan standards, he was middle class, and his father was a hardworking teacher at a neighborhood school. It would take a series of lucky breaks for this gifted scientist to wend his way to the Ph.D. program at Harvard University, becoming the first scientist to clone HIV subtype C--the most prevalen...
Source: Scientific American Topic - Biotechnology - June 18, 2012 Category: Biotechnology Tags: Health,Society & Policy,Everyday Science,More Science,Pharmaceuticals,Biotechnology,Biotechnology,Infectious Diseases,Medical Technology,Biology,Science Education Source Type: news

India, US sign agreement on collaboration in Diabetes research
The primary aim of this collaboration is to initiate a health research relationship between the two countries.
Source: The Economic Times Healthcare and Biotech News - June 18, 2012 Category: Pharmaceuticals Source Type: news

Can Florida's biotech projects be weaned off subsidies?
TALLAHASSEE — Dr. Stephen Gardell looks over Orlando's slowly materializing $2 billion Medical City and says his team hasn't lost sight of the "grand plan": a cluster of labs, hospitals and classrooms that will allow new technologies to advance from...
Source: OrlandoSentinel: Medical Research - June 17, 2012 Category: American Health Source Type: news

Ranbaxy and Dr Reddy's to take a hit as Lipitor market shrinks 96%
Analysts expect prices of atorvastatin, generic version of Lipitor, to drop further as additional players enter the market.
Source: The Economic Times Healthcare and Biotech News - June 15, 2012 Category: Pharmaceuticals Source Type: news

Human-Eye Precursor Grown from Stem Cell
From Nature magazine [More]
Source: Scientific American Topic - Stem Cell Research - June 15, 2012 Category: Stem Cells Tags: Health,Medical Technology,Biotechnology,Biotechnology,Biology,More Science Source Type: news

Whole Genome DNA Sequencing's Impact on Health Care
Advances in high throughput DNA sequencing are bringing costs down to the point where this technology can transition from basic research to a routine medical use. However, there is a lot of discussion how this new extensive genetic information will really affect health care....Read Full Post
Source: About.com Biotech Biomedical - June 15, 2012 Category: Biotechnology Source Type: news

Roche Closing NimbleGen and Pulling Out of DNA Microarray Market
Following the collapse of Roche's attempted acquisition of Illumina, Roche continues to try and sort out its genomics strategy. A couple weeks ago, Roche announced it would be closing down its Nimblegen DNA microarray business. Roche will cease all Nimblegen operations in Iceland and Europe, and cut out half the US operation in Madison, eliminating about 120 employees....Read Full Post
Source: About.com Biotech Biomedical - June 15, 2012 Category: Biotechnology Source Type: news

Acorda initiates proof-of-concept study of Ampyra
Acorda Therapeutics, a biotechnology company, has enrolled the first patient in an Ampyra (dalfampridine) proof-of-concept study in patients with post-stroke deficits.
Source: Drug Development Technology - June 14, 2012 Category: Pharmaceuticals Source Type: news

Tata Group weighs options to exit Advinus Therapeutics
Tata Group-owned drug discovery and services firm Advinus Therapeutics has initiated talks with a few foreign drug companies that could lead it to exit the company.
Source: The Economic Times Healthcare and Biotech News - June 14, 2012 Category: Pharmaceuticals Source Type: news

Timber Creek student wins scholarship with paid medical internships
It wasn't so long ago that the lab rat was supposed to displace Mickey as the state's most important rodent. Turns out Mickey doesn't have anything to worry about. The biotechnology industry and its rats are nowhere close to nudging tourism out of the...
Source: OrlandoSentinel: Medical Research - June 14, 2012 Category: American Health Source Type: news

Dendreon Shareholders Complain About Stock Losses
[the Seattle Times] From Seattle Times (WA) (June 13, 2012) June 13--Dendreon shareholders strafed the Seattle biotechnology company’s leadership with criticism at Wednesday’s annual...
Source: Drugs.com - Pharma News - June 14, 2012 Category: Pharmaceuticals Source Type: news

Small Comfort: Nanomedicine Able to Penetrate Bodily Defenses
Tears and a runny nose can be unpleasant on a windy day, but these mucosal secretions play a vital role in protecting the body from viruses and other malicious microbes. Unfortunately, mucus is also adept at washing away medication designed to treat infections and inflammation that occur when an infectious agent is successful in penetrating the body's defenses [More]
Source: Scientific American Topic - Biotechnology - June 14, 2012 Category: Biotechnology Tags: Technology,Chemistry,Health,Pharmaceuticals,Biotechnology,Biotechnology,Infectious Diseases,Medical Technology,Biology,More Science Source Type: news